Midgard Science

Labs / Assays & in vitro testing

Parabilis Medicines

Cambridge, MA, United States · parabilismed.com

Parabilis Medicines is a biotechnology company developing ultra-tunable peptide therapeutics based on its Helicon platform. It focuses on discovering and advancing medicines for serious diseases, including cancer and other hard-to-treat targets, from Cambridge, Massachusetts.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Helicon drug discovery platform

    Integrates AI, physics-based computational modeling, high-throughput peptide synthesis, and experimental screening to discover and develop drug candidates.

  • Helicon design and optimization

    Uses computational methods and experimental validation to design and optimize stabilized helical peptide therapeutics for difficult targets.

  • Multiplexed display screening

    Uses multiplexed display screening to systematically explore and identify Helicon candidates.

  • Co-optimization platform

    Applies integrated experimental and computational workflows to co-optimize Helicon therapeutic properties.

What they work on

Modalities
Small molecule, Antibody, Peptide
Assays and studies
high-throughput peptide synthesis, experimental screening, multiplexed display screening, co-optimization, AI- and physics-based computational modeling
Scale and capacity
millions of data points, hundreds of thousands of Helicons, dozens of drug-like properties
Therapeutic areas
serious diseases, cancer
Sites
Cambridge, United States
Address
9510 Cambridge Discovery Park 30 Acorn Park Drive, Cambridge, MA 02140

Similar labs. Aurigene Pharmaceutical Services, Avantia Labs, Biofidus GmbH, Bioklone Biotech Private Limited

Found in a contract services directory. Listing built from parabilismed.com. Work here? Claim this listing.

Parabilis Medicines · Midgard Science